Mounjaro®
Starting from £179.99/mo
Start journey Learn moreFatigue and sleepiness are recognised side effects of Mounjaro (tirzepatide). They appear most often in the first few weeks of treatment or after a dose increase, tend to be mild, and usually settle as the body adjusts. They are not a sign that something has gone seriously wrong. That said, the right question is whether tiredness is part of the expected adjustment picture or a signal worth discussing with your prescriber — and that is exactly what this page covers. Mounjaro is a prescription-only medicine; any concerns about how it is affecting you should be raised with the clinician responsible for your care.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
This is the decision most people are really trying to make. Fatigue during weight-loss treatment can come from several directions at once, which makes it harder to pin on any single cause.
Tirzepatide works partly by slowing gastric emptying and reducing appetite. A meaningful drop in calorie intake (which is the point) means the body is running on less fuel than it was. That shift alone can leave people feeling more tired than usual, particularly in the early weeks. It is one of the most common misconceptions to assume that tiredness on Mounjaro is purely pharmacological; often the body is simply adjusting to eating less while also processing a significant hormonal and metabolic change.
On top of that, gastrointestinal side effects like nausea or disturbed digestion can fragment overnight sleep without people fully registering it. Poor sleep quality then shows up as daytime drowsiness. You will find a detailed look at how Mounjaro relates to sleep quality and night-time wakefulness on our Mounjaro and sleep page.
The NHS lists fatigue as a common side effect of tirzepatide in its patient-level medicines guidance, placing it alongside dizziness and headache as effects that are typically more noticeable early in treatment or after a step up in dose. NHS guidance on tirzepatide advises resting, staying hydrated and giving the body time to settle.
If the tiredness is affecting your ability to drive, work or function safely, that is worth acting on rather than riding out.
Timing matters here. Most people who report fatigue notice it most sharply in the first one to two weeks after starting treatment, or immediately following a dose increase. The starter dose (2.5 mg) exists to give the body a gentler introduction to the medicine before the prescriber moves upward through the schedule, and this phased approach is specifically intended to limit the severity of early side effects including tiredness.
For the majority of people, fatigue eases considerably as the weeks progress at a given dose. The system adapts: appetite regulation stabilises, eating patterns settle into the new normal, and the acute metabolic adjustment calms down. Anecdotally, people who stay well-hydrated, keep protein intake reasonable and do not drastically cut calories beyond what the medicine naturally achieves tend to report less prolonged fatigue.
Fatigue that does not follow this pattern (that is, tiredness which arrives later, is getting steadily worse, or is accompanied by other symptoms) sits in a different category. Unexplained fatigue persisting beyond a month at a stable dose, or fatigue arriving alongside symptoms such as low mood, significant weakness or unexpected breathlessness, deserves a clinical conversation rather than further waiting. Your prescriber can help determine whether a dose adjustment or a different explanation is more likely.
For context on how tirzepatide affects energy and rest more broadly, the tirzepatide and sleep page covers the evidence in more detail.
You do not need to make a binary choice between pushing through and stopping treatment. There are some practical measures worth trying first, and some clear signals that move this from a wait-and-see situation to a call your prescriber today one.
On the practical side: prioritise protein at each meal to offset any muscle-energy dip from lower overall intake; drink enough water throughout the day, since even mild dehydration amplifies fatigue; and be cautious about also cutting carbohydrates drastically while on Mounjaro — the medicine is already reducing intake significantly. Gentle physical activity can help regulate energy levels and improve overnight sleep quality, though exhausting exercise when already fatigued is counterproductive.
If you have found yourself lying awake at night and wondering whether the medication itself is the cause, our page on whether Mounjaro stops you sleeping works through that question in detail. For anyone already experiencing disrupted nights, there is also dedicated guidance on not sleeping on Mounjaro, including practical steps that may help.
For anyone weighing up the broader picture of their treatment (including how Mounjaro compares to other options and what private treatment costs) our Mounjaro price comparison page offers a clear, factual overview. There is also detailed coverage of how tirzepatide affects visceral fat for those curious about the mechanisms behind the metabolic changes.
Call your prescriber or seek urgent medical advice if: fatigue is severe and sudden; it is accompanied by persistent, severe abdominal pain that radiates to the back (which requires urgent assessment given the known risk of pancreatitis with GLP-1 medicines, as noted in the MHRA's Drug Safety Updates); there are signs of dehydration after vomiting or diarrhoea; or you feel unable to carry out normal daily activities safely. These are the situations where waiting is not the right answer.
If you are thinking about starting treatment and want to discuss your personal health picture with a prescriber, you can check your eligibility with our clinical team.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.